LHX vs RTX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
LHX exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a conservative Debt/Equity ratio of 0.35. However, the stock is trading at a significant premium, with a current price of $324.88 far exceeding both the Graham Number ($140.53) and the growth-based Intrinsic Value ($59.78). While a massive $38.7 billion contractual backlog provides excellent revenue visibility, negative YoY earnings growth and bearish insider activity temper the bullish analyst consensus. The overall profile is that of a high-quality company currently priced for perfection.
RTX exhibits stable financial health with a Piotroski F-Score of 5/9, yet it is trading at a severe premium compared to its Graham Number ($73.73) and Intrinsic Value ($96.67). While the company boasts an exceptional track record of earnings beats over 25 quarters and solid revenue growth, the valuation is stretched with a PEG ratio of 2.75. This fundamental overvaluation is compounded by bearish insider sentiment and a weak technical trend, suggesting that while the business is strong, the stock price is currently decoupled from its deterministic value.
Compare Another Pair
Related Comparisons
LHX vs RTX: Head-to-Head Comparison
This page compares L3Harris Technologies, Inc. (LHX) and RTX Corporation (RTX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.